Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veliparib with Radiation and Temozolomide in Pediatric DIPG
NCT01514201Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Feb 2012
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of veliparib in diffuse intrinsic pontine glioma (DIPG), sponsored by National Cancer Institute. Started Feb 2012; status: completed.
02
Drugs
veliparib
03
Conditions
diffuse intrinsic pontine glioma (DIPG)
Beyond the preview
Go deeper on NCT01514201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01514201.